Crossmark

Multitarget evaluation of 4-substituted 7-hydroxycoumarin derivatives: anticancer activity, topoisomerase I inhibition, and interaction with human serum albumin

Crossref DOI link: https://doi.org/10.1007/s00210-026-05062-w

Published Online: 2026-02-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gucký, Adrián

Majerník, Martin

Hamuľaková, Slávka

Nowak, Katarzyna E.

Jendželovský, Rastislav

Fedoročko, Peter

Kožurková, Mária
Funding

Funding for this research was provided by:

Internal Scientific Grant System of Pavol Jozef Šafárik University in Košic (VVGS grant no. 2023-2742)

Slovak Grant Agency of the Ministry of Education, Research, Development and Youth of the Slovak Republic (VEGA grant no. 1/0037/22)

EU NextGenerationEU through the Recovery and Resilience Plan for Slovakia under the projec (No. 09-I02-03-V01-00021)

Pavol Jozef Šafárik University in Košice
License Information

Text and Data Mining valid from 2026-02-12

Version of Record valid from 2026-02-12
More Information

Article History

Received: 7 October 2025

Accepted: 26 January 2026

First Online: 12 February 2026

Declarations

:

: The authors have no relevant financial or non-financial interests to disclose.

Document is current

Any future updates will be listed below